Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead
Shu‐Jin Li, Zhi‐Jun Sun
Cancer Letters (2022) Vol. 550, pp. 215937-215937
Closed Access | Times Cited: 11

Showing 11 citing articles:

Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 9
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
Cancers (2023) Vol. 15, Iss. 16, pp. 4178-4178
Open Access | Times Cited: 14
m1A inhibition fuels oncolytic virus-elicited antitumor immunity via downregulating MYC/PD-L1 signaling
Shu‐Jin Li, Feng Tian, Yuan‐Tong Liu, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Novel intelligent Bayesian computing networks for predictive solutions of nonlinear multi-delayed tumor oncolytic virotherapy systems
Nabeela Anwar, Iftikhar Ahmad, Adiqa Kausar Kiani, et al.
International Journal of Biomathematics (2023) Vol. 17, Iss. 07
Closed Access | Times Cited: 12
Oncolytic Virus‐Driven Biotherapies from Bench to Bedside
Shijie Duan, Shuhang Wang, Lei Qiao, et al.
Small (2023) Vol. 19, Iss. 23
Closed Access | Times Cited: 11
Deciphering the tumor-suppressive role of PSMB9 in melanoma through multi-omics and single-cell transcriptome analyses
Xing Hu, Zhengang Hu, Hao Zhang, et al.
Cancer Letters (2023) Vol. 581, pp. 216466-216466
Closed Access | Times Cited: 9
Nanomedicine Targeting Myeloid‐Derived Suppressor Cells Enhances Anti‐Tumor Immunity
En‐Li Yang, Zhi‐Jun Sun
Advanced Healthcare Materials (2024) Vol. 13, Iss. 9
Closed Access | Times Cited: 3
Oncolytic Viruses and Immune Checkpoint Inhibitors: The “Hot” New Power Couple
Charlotte Lovatt, Alan L. Parker
(2023)
Open Access | Times Cited: 7
Nanomaterials augmented bioeffects of ultrasound in cancer immunotherapy
Xinxin Xie, Jinxia Zhang, Yuan Wang, et al.
Materials Today Bio (2023) Vol. 24, pp. 100926-100926
Open Access | Times Cited: 5
Tuning Cellular Metabolism for Cancer Virotherapy
Dian Xiong, Qing Wang, Weiming Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216924-216924
Closed Access | Times Cited: 1
HSV: The scout and assault for digestive system tumors
Sheng Li, Qingbo Li, Yi Ren, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 3
Page 1

Scroll to top